These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29969986)

  • 1. Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
    Minchin RF; Butcher NJ
    BMC Genomics; 2018 Jul; 19(1):513. PubMed ID: 29969986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
    Endo Y; Yamashita H; Takahashi S; Sato S; Yoshimoto N; Asano T; Hato Y; Dong Y; Fujii Y; Toyama T
    BMC Cancer; 2014 Dec; 14():990. PubMed ID: 25528056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5
    Zhang X; Carlisle SM; Doll MA; Martin RCG; States JC; Klinge CM; Hein DW
    J Pharmacol Exp Ther; 2018 Apr; 365(1):84-93. PubMed ID: 29339455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
    Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of NAT1 pharmacogene in hormone receptor positive vs. negative female breast tumors may affect drug treatment.
    Ivanova D; Fakis G; Boukouvala S
    Pharmacogenet Genomics; 2024 Sep; 34(7):246-251. PubMed ID: 38842463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues.
    Kim SJ; Kang HS; Jung SY; Min SY; Lee S; Kim SW; Kwon Y; Lee KS; Shin KH; Ro J
    J Mol Med (Berl); 2010 Nov; 88(11):1123-31. PubMed ID: 20628863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Carlisle SM; Hein DW
    Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylamine
    Li P; Butcher NJ; Minchin RF
    Mol Pharmacol; 2019 Nov; 96(5):573-579. PubMed ID: 31444237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
    Bièche I; Girault I; Urbain E; Tozlu S; Lidereau R
    Breast Cancer Res; 2004; 6(3):R252-63. PubMed ID: 15084249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer.
    Kim SJ; Kang HS; Chang HL; Jung YC; Sim HB; Lee KS; Ro J; Lee ES
    Oncol Rep; 2008 Mar; 19(3):663-8. PubMed ID: 18288399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
    McAleese CE; Butcher NJ; Minchin RF
    Breast Cancer Res Treat; 2022 Oct; 195(3):223-236. PubMed ID: 35918499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
    Johansson I; Nilsson C; Berglund P; Lauss M; Ringnér M; Olsson H; Luts L; Sim E; Thorstensson S; Fjällskog ML; Hedenfalk I
    Breast Cancer Res; 2012 Feb; 14(1):R31. PubMed ID: 22333393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.
    Tiang JM; Butcher NJ; Cullinane C; Humbert PO; Minchin RF
    PLoS One; 2011 Feb; 6(2):e17031. PubMed ID: 21347396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
    Rodrigues-Lima F; Dairou J; Busi F; Dupret JM
    Curr Drug Targets; 2010 Jun; 11(6):759-66. PubMed ID: 20041842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
    Salazar-González RA; Turiján-Espinoza E; Hein DW; Niño-Moreno PC; Romano-Moreno S; Milán-Segovia RC; Portales-Pérez DP
    Arch Toxicol; 2018 Feb; 92(2):661-668. PubMed ID: 29043425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct.
    Millner LM; Doll MA; Stepp MW; States JC; Hein DW
    Carcinogenesis; 2012 Feb; 33(2):348-55. PubMed ID: 22114069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk.
    Zheng W; Deitz AC; Campbell DR; Wen WQ; Cerhan JR; Sellers TA; Folsom AR; Hein DW
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):233-9. PubMed ID: 10090301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.